Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA Cites Risks in Diabetes Drug
FDA Cites Risks in Diabetes Drug
FDA Cites Risks in Diabetes Drug
Submitted by
admin
on July 17, 2011 - 12:04pm
Source:
Motley Fool
News Tags:
AstraZeneca
Bristol-Myers Squibb
Dapagliflozin
diabetes
Headline:
FDA Cites Risks in Diabetes Drug
Do Not Allow Advertisers to Use My Personal information
